Opko Health Inc. (NYSE:OPK) insider has recently participated in insider trading activity. CEO & Chairman, FROST PHILLIP MD ET AL bought 16,000 shares for $144,177 via one transaction Jun 14. Following the transaction, the insider now owns 159,760,743 shares in total, priced at $1482579695.04 as of Thursday. Another notable insider trading was done by the same insider on Jun 10. FROST PHILLIP MD ET AL acquired 10,000 shares at an average price of $9.36 for a total of $93,579. Moreover, this insider carried out a buy of 11,200 shares at $9.80 each on Jun 08. The transaction amounted to $109,752. The insider also bought 5,000 shares for $49,499 through one transaction Jun 07.
The stock has experienced a total of 30 insider trades in the past three months. These trades include 2 sell activities and 28 buy trades. Furthermore, over the past 12 months, the stock was traded 147 times by insiders. In 7 of these trades, the insider was a seller while an employee of the company was the buyer in just 140 instances.
Opko Health Inc. (OPK) on June 13, 2016 announced that it will move its stock exchange listing to The NASDAQ Stock Market from The New York Stock Exchange (the “NYSE”). The Company expects its common stock will begin trading on the NASDAQ Global Select Market (“NASDAQ”) on June 24, 2016, and its shares will continue to trade under the ticker symbol “OPK.”
“NASDAQ is home to many of the world’s best healthcare companies and is a natural fit for OPKO. This move will enhance our public visibility while offering our stockholders cost effective access to advanced trading technologies,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO.
Bob Greifeld, CEO of Nasdaq, said, “Under the leadership of Dr. Frost, OPKO has long been recognized for driving innovation in the pharmaceutical and diagnostics industries to create products that improve our lives. We are proud to welcome the company to Nasdaq.”
The Company has notified the NYSE that it will voluntarily delist its common stock from the NYSE. The last day of trading of the common stock on the NYSE is expected to be on or about June 23, 2016. Until the Company’s Common Stock begins trading on NASDAQ, the Company’s Common Stock will remain trading on NYSE under the ticker symbol “OPK.”